Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Heska price target raised to $240 from $220 at Piper Sandler » 04:56
05/10/21
05/10
04:56
05/10/21
04:56
HSKA

Heska

$200.39 /

-3.61 (-1.77%)

Piper Sandler analyst…

Piper Sandler analyst Steven Mah raised the firm's price target on Heska to $240 from $220 and keeps an Overweight rating on the shares following the Q1 results. The analyst believes Heska is well positioned for long-term growth with macro pet trends are expected to be durable.

ShowHide Related Items >><<
HSKA Heska
$200.39 /

-3.61 (-1.77%)

HSKA Heska
$200.39 /

-3.61 (-1.77%)

05/07/21 Alliance Global Partners
Heska price target raised to $240 from $230 at Alliance Global Partners
02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
HSKA Heska
$200.39 /

-3.61 (-1.77%)

  • 03
    Mar
HSKA Heska
$200.39 /

-3.61 (-1.77%)

Friday
Recommendations
Heska price target raised to $240 from $230 at Alliance Global Partners » 11:36
05/07/21
05/07
11:36
05/07/21
11:36
HSKA

Heska

$202.37 /

-1.63 (-0.80%)

Alliance Global Partners…

Alliance Global Partners analyst Ben Haynor raised the firm's price target on Heska to $240 from $230 and keeps a Buy rating on the shares after the company reported total revenue and results on each revenue line that topped his expectations. While Heska is clearly benefiting from a strong veterinary diagnostics market, there are signs that the company continues to perform better than the industry, according to Haynor, who has "significantly" increased his estimates.

ShowHide Related Items >><<
HSKA Heska
$202.37 /

-1.63 (-0.80%)

HSKA Heska
$202.37 /

-1.63 (-0.80%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
HSKA Heska
$202.37 /

-1.63 (-0.80%)

  • 03
    Mar
HSKA Heska
$202.37 /

-1.63 (-0.80%)

Thursday
Earnings
Heska reports Q1 non-GAAP EPS 59c, consensus (41c) » 08:28
05/06/21
05/06
08:28
05/06/21
08:28
HSKA

Heska

$188.04 /

-6.96 (-3.57%)

Reports Q1 revenue…

Reports Q1 revenue $60.5M, consensus $52.45M. "I'm pleased to report a great start to the year," commented CEO Kevin Wilson. "In our North America segment, POC Lab Consumables sales grew 23.9% from expanding utilization, good market share, expanding menu, and strong end-user demand. Imaging grew 91.3%, benefiting from the work we did last year to reorganize and expand our sales force into a unified, customer-location structure. Our International segment delivered a very solid start to the year in nearly all geographies, with great momentum in POC Lab Consumables and adoption of our subscriptions model in select European markets. (...) Also in Q1, we successfully raised substantial growth capital to go faster in launching new analyzer platforms, new test menus, new diagnostics services, and new international initiatives. While we are mindful of our competition and of the universal tendency for things to be difficult while going faster, the strong beginning to 2021 and the favorable setup for the rest of the year is highly encouraging. Our underlying markets are well positioned for the current macro-economic environment".

ShowHide Related Items >><<
HSKA Heska
$188.04 /

-6.96 (-3.57%)

HSKA Heska
$188.04 /

-6.96 (-3.57%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
HSKA Heska
$188.04 /

-6.96 (-3.57%)

  • 03
    Mar
HSKA Heska
$188.04 /

-6.96 (-3.57%)

Over a month ago
Options
new option listings on March 24th » 08:30
03/24/21
03/24
08:30
03/24/21
08:30
ACET

Adicet Bio

$14.12 /

-0.39 (-2.69%)

, ALUS

Alussa Energy Acquisition

$10.15 /

-0.115 (-1.12%)

, ANIX

Anixa Biosciences

$4.80 /

-1.975 (-29.17%)

, ATHA

Athira Pharma

$18.52 /

-0.46 (-2.42%)

, BBAX

JPMorgan BetaBuilders Developed Asia ex-Japan ETF

$28.04 /

-0.38085 (-1.34%)

, BBJP

JPMorgan BetaBuilders Japan ETF

$28.74 /

-0.44 (-1.51%)

, BWEN

Broadwind

$5.25 /

-0.33 (-5.91%)

, CBLI

Cleveland BioLabs

$5.66 /

-0.48 (-7.82%)

, EQ

Equillium

$7.47 /

-0.64 (-7.89%)

, FBIO

Fortress Biotech

$3.94 /

-0.23 (-5.52%)

, FDMT

4D Molecular

$43.32 /

-1.24 (-2.78%)

, FLOT

iShares Floating Rate Bond ETF

$50.80 /

+ (+0.00%)

, HSKA

Heska

$172.40 /

-4.79 (-2.70%)

, IMAB

I-MAB

$48.85 /

-4.56 (-8.54%)

, JPST

JPS Industries

$50.75 /

+0.005 (+0.01%)

, LIZI

Lizhi

$8.61 /

-0.76 (-8.11%)

, OLMA

Olema Oncology

$37.68 /

+0.01 (+0.03%)

, PLRX

Pliant Therapeutics

$38.25 /

+0.17 (+0.45%)

, RAAS

Cloopen

$19.65 /

-0.165 (-0.83%)

, RPTX

Repare Therapeutics

$28.44 /

-2.4 (-7.78%)

, SCR

Score Media

$27.19 /

-0.04 (-0.15%)

, SLGG

Super League Gaming

$8.40 /

-1.02 (-10.83%)

, TFII

TFI International

$72.00 /

-2.82 (-3.77%)

, ZNTL

Zentalis

$42.41 /

-5.28 (-11.07%)

New option listings for…

New option listings for March 24th include Adicet Bio (ACET), Alussa Energy Acquisition Corp (Class A Stock) (ALUS), Anixa Biosciences Inc (ANIX), Athira Pharma Inc (ATHA), JPMorgan BetaBuilders Developed Asiaex Japan ETF (BBAX), JPMorgan BetaBuilders International Equity (BBIN), JPMorgan BetaBuilders Japan ETF (BBJP), Broadwind Energy (BWEN), Cleveland BioLabs (CBLI), Global X (COPX), Global X SuperDividend US (DIV), Equillium Inc (EQ), Fortress Biotech (FBIO), 4D Molecular Therapeutics Inc (FDMT), iShares Floating Rate (FLOT), Heska (HSKA), I MAB (ADS) (IMAB), Jpmorgan Equity Premium Income ETF (JEPI), JPMorgan Ultra-Short Income ETF (JPST), LIZHI Inc (ADS) (LIZI), Olema Pharmaceuticals Inc (OLMA), Pliant Therapeutics Inc (PLRX), Cloopen Group Holding Limited (Class A ADS) (RAAS), First Trust NASDAQ Rising Dividend Achievers (RDVY), Repare Therapeutics Inc (RPTX), Score Media and Gaming Inc (Class A Stock) (SCR), Super League Gaming Inc (SLGG), TFI International Inc (TFII), and Zentalis Pharmaceuticals Inc (ZNTL).

ShowHide Related Items >><<
ZNTL Zentalis
$42.41 /

-5.28 (-11.07%)

TFII TFI International
$72.00 /

-2.82 (-3.77%)

SLGG Super League Gaming
$8.40 /

-1.02 (-10.83%)

RAAS Cloopen
$19.65 /

-0.165 (-0.83%)

PLRX Pliant Therapeutics
$38.25 /

+0.17 (+0.45%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

IMAB I-MAB
$48.85 /

-4.56 (-8.54%)

HSKA Heska
$172.40 /

-4.79 (-2.70%)

FDMT 4D Molecular
$43.32 /

-1.24 (-2.78%)

FBIO Fortress Biotech
$3.94 /

-0.23 (-5.52%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

CBLI Cleveland BioLabs
$5.66 /

-0.48 (-7.82%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

ANIX Anixa Biosciences
$4.80 /

-1.975 (-29.17%)

ALUS Alussa Energy Acquisition
$10.15 /

-0.115 (-1.12%)

ACET Adicet Bio
$14.12 /

-0.39 (-2.69%)

ACET Adicet Bio
$14.12 /

-0.39 (-2.69%)

11/04/20
Fly Intel: Top five analyst initiations
11/04/20 B. Riley
B. Riley sees 200% potential upside in 'attractive value play' Adicet Bio
11/04/20 B. Riley
Adicet Bio initiated with a Buy at B. Riley Securities
10/27/20 JMP Securities
Adicet Bio initiated with an Outperform at JMP Securities
ALUS Alussa Energy Acquisition
$10.15 /

-0.115 (-1.12%)

ANIX Anixa Biosciences
$4.80 /

-1.975 (-29.17%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

10/13/20 Jefferies
Athira Pharma initiated with a Buy at Jefferies
10/13/20 JMP Securities
Athira Pharma initiated with an Outperform at JMP Securities
10/13/20 Stifel
Athira Pharma initiated with a Buy at Stifel
10/13/20 Goldman Sachs
Athira Pharma initiated with a Buy at Goldman Sachs
BBAX JPMorgan BetaBuilders Developed Asia ex-Japan ETF
$28.04 /

-0.38085 (-1.34%)

BBJP JPMorgan BetaBuilders Japan ETF
$28.74 /

-0.44 (-1.51%)

BWEN Broadwind
$5.25 /

-0.33 (-5.91%)

01/26/21 Roth Capital
Broadwind price target raised to $12.50 from $4 at Roth Capital
01/26/21 H.C. Wainwright
Broadwind downgraded to Neutral from Buy at H.C. Wainwright
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
CBLI Cleveland BioLabs
$5.66 /

-0.48 (-7.82%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
FBIO Fortress Biotech
$3.94 /

-0.23 (-5.52%)

02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
12/14/20 Benchmark
Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
10/13/20 B. Riley
Fortress Biotech weakness on Avenue CRL overblown, says B. Riley Securities
10/12/20 H.C. Wainwright
H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL
FDMT 4D Molecular
$43.32 /

-1.24 (-2.78%)

01/05/21 Evercore ISI
4D Molecular initiated with an Outperform at Evercore ISI
01/05/21 BofA
4D Molecular initiated with a Buy at BofA
01/05/21 Goldman Sachs
4D Molecular initiated with a Neutral at Goldman Sachs
FLOT iShares Floating Rate Bond ETF
$50.80 /

+ (+0.00%)

HSKA Heska
$172.40 /

-4.79 (-2.70%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
IMAB I-MAB
$48.85 /

-4.56 (-8.54%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
JPST JPS Industries
$50.75 /

+0.005 (+0.01%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

OLMA Olema Oncology
$37.68 /

+0.01 (+0.03%)

12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
12/14/20 Canaccord
Olema Pharmaceuticals initiated with a Buy at Canaccord
12/14/20 Cowen
Olema Pharmaceuticals initiated with an Outperform at Cowen
PLRX Pliant Therapeutics
$38.25 /

+0.17 (+0.45%)

08/11/20 Piper Sandler
Pliant Therapeutics' approach to fibrotic diseases best in industry, says Piper
06/29/20 Needham
Pliant Therapeutics initiated with a Buy at Needham
06/29/20 Cowen
Pliant Therapeutics initiated with an Outperform at Cowen
06/29/20 Citi
Pliant Therapeutics initiated with a Buy at Citi
RAAS Cloopen
$19.65 /

-0.165 (-0.83%)

03/09/21 Citi
Cloopen initiated with a Buy, $27 price target at Citi
03/08/21 Citi
Cloopen initiated with a Buy at Citi
03/06/21 Goldman Sachs
Cloopen initiated with a Neutral at Goldman Sachs
RPTX Repare Therapeutics
$28.44 /

-2.4 (-7.78%)

03/01/21 Berenberg
Repare Therapeutics initiated with a Buy at Berenberg
12/29/20 Northland
Northland ups Repare Therapeutics price target to $42, calls a Top Pick for 2021
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Northland
Repare Therapeutics initiated with an Outperform at Northland
SCR Score Media
$27.19 /

-0.04 (-0.15%)

03/23/21 Credit Suisse
Score Media initiated with an Outperform at Credit Suisse
03/22/21 Macquarie
Score Media initiated with an Outperform at Macquarie
SLGG Super League Gaming
$8.40 /

-1.02 (-10.83%)

03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
02/09/21 Alliance Global Partners
Super League downgraded on 'rich' valuation at Alliance Global
02/09/21 Alliance Global Partners
Super League Gaming downgraded to Neutral from Buy at Alliance Global Partners
TFII TFI International
$72.00 /

-2.82 (-3.77%)

02/12/21 UBS
TFI International downgraded to Neutral from Buy at UBS
02/10/21 National Bank
TFI International price target raised to C$110 from C$103 at National Bank
02/10/21 Desjardins
TFI International price target raised to C$108 from C$102 at Desjardins
02/10/21 TD Securities
TFI International price target raised to C$115 from C$110 at TD Securities
ZNTL Zentalis
$42.41 /

-5.28 (-11.07%)

01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
09/28/20 Cantor Fitzgerald
Zentalis initiated with an Overweight at Cantor Fitzgerald
08/27/20 H.C. Wainwright
Zentalis initiated with a Buy at H.C. Wainwright
ZNTL Zentalis
$42.41 /

-5.28 (-11.07%)

RPTX Repare Therapeutics
$28.44 /

-2.4 (-7.78%)

PLRX Pliant Therapeutics
$38.25 /

+0.17 (+0.45%)

OLMA Olema Oncology
$37.68 /

+0.01 (+0.03%)

HSKA Heska
$172.40 /

-4.79 (-2.70%)

FBIO Fortress Biotech
$3.94 /

-0.23 (-5.52%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

BWEN Broadwind
$5.25 /

-0.33 (-5.91%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

  • 03
    Mar
  • 25
    Feb
  • 10
    Feb
  • 09
    Feb
  • 09
    Feb
  • 21
    Jan
  • 13
    Jan
  • 11
    Dec
  • 19
    Nov
  • 24
    Sep
  • 18
    Sep
  • 27
    Aug
  • 14
    Aug
  • 13
    Aug
  • 30
    Jul
  • 19
    Jun
  • 03
    Jun
  • 03
    Apr
SCR Score Media
$27.19 /

-0.04 (-0.15%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

SCR Score Media
$27.19 /

-0.04 (-0.15%)

RAAS Cloopen
$19.65 /

-0.165 (-0.83%)

OLMA Olema Oncology
$37.68 /

+0.01 (+0.03%)

LIZI Lizhi
$8.61 /

-0.76 (-8.11%)

FDMT 4D Molecular
$43.32 /

-1.24 (-2.78%)

EQ Equillium
$7.47 /

-0.64 (-7.89%)

CBLI Cleveland BioLabs
$5.66 /

-0.48 (-7.82%)

BWEN Broadwind
$5.25 /

-0.33 (-5.91%)

ATHA Athira Pharma
$18.52 /

-0.46 (-2.42%)

ACET Adicet Bio
$14.12 /

-0.39 (-2.69%)

BBAX JPMorgan BetaBuilders Developed Asia ex-Japan ETF
$28.04 /

-0.38085 (-1.34%)

Syndicate
Heska 941K share Secondary priced at $186.00 » 06:26
03/03/21
03/03
06:26
03/03/21
06:26
HSKA

Heska

$189.61 /

-11.69 (-5.81%)

The deal size was…

The deal size was increased to $175M in common stock from $150M in common stock. JPMorgan and Piper Sandler acted as joint book running managers for the offering.

ShowHide Related Items >><<
HSKA Heska
$189.61 /

-11.69 (-5.81%)

HSKA Heska
$189.61 /

-11.69 (-5.81%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
HSKA Heska
$189.61 /

-11.69 (-5.81%)

  • 03
    Mar
Syndicate
Heska files automatic mixed securities shelf  16:18
03/01/21
03/01
16:18
03/01/21
16:18
HSKA

Heska

$200.64 /

+12.85 (+6.84%)

 
ShowHide Related Items >><<
HSKA Heska
$200.64 /

+12.85 (+6.84%)

HSKA Heska
$200.64 /

+12.85 (+6.84%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
HSKA Heska
$200.64 /

+12.85 (+6.84%)

Syndicate
Heska announces $150M common stock offering » 16:10
03/01/21
03/01
16:10
03/01/21
16:10
HSKA

Heska

$200.64 /

+12.85 (+6.84%)

Heska Corporation…

Heska Corporation announced that it has commenced an underwritten public offering of $150M of shares of its common stock. Heska intends to use the net proceeds from the offering for general corporate purposes, including working capital, further development and potential commercialization of current and future product initiatives, collaborations, and capital expenditures. Heska may also use a portion of the net proceeds of this offering to fund possible investments in or acquisitions of complementary businesses, products or technologies, or to repay indebtedness. However, it has no agreements or commitments to do so. J.P. Morgan and Piper Sandler are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
HSKA Heska
$200.64 /

+12.85 (+6.84%)

HSKA Heska
$200.64 /

+12.85 (+6.84%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
HSKA Heska
$200.64 /

+12.85 (+6.84%)

Conference/Events
BofA to hold a virtual summit » 10:23
02/25/21
02/25
10:23
02/25/21
10:23
HSKA

Heska

$207.78 /

-0.35 (-0.17%)

, ZTS

Zoetis

$158.94 /

-0.1 (-0.06%)

, KIN

Kindred Biosciences

$4.74 /

+0.03 (+0.64%)

, IDXX

Idexx Laboratories

$529.59 /

-3.96 (-0.74%)

, PAHC

Phibro Animal Health

$21.80 /

-0.04 (-0.18%)

, ELAN

Elanco

$32.14 /

+0.57 (+1.81%)

Animal Health Virtual…

Animal Health Virtual Summit 2021 to be held on February 25.

ShowHide Related Items >><<
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

KIN Kindred Biosciences
$4.74 /

+0.03 (+0.64%)

IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

HSKA Heska
$207.78 /

-0.35 (-0.17%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

HSKA Heska
$207.78 /

-0.35 (-0.17%)

02/24/21 Alliance Global Partners
Heska price target raised to $230 from $167.50 at Alliance Global Partners
02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

02/17/21 Credit Suisse
Zoetis price target raised to $203 from $197 at Credit Suisse
11/12/20 Truist
Zoetis price target raised to $170 from $160 at Truist
11/06/20 Barclays
Zoetis price target raised to $189 from $175 at Barclays
09/21/20 Atlantic Equities
Zoetis initiated with an Overweight at Atlantic Equities
KIN Kindred Biosciences
$4.74 /

+0.03 (+0.64%)

12/24/20 Barclays
Kindred atopic dermatitis portfolio could net $130M in sales, says Barclays
12/18/20 Alliance Global Partners
Kindred Biosciences price target lowered to $9.25 from $10.25 at Alliance Global Partners
12/14/20 Lake Street
Kindred Biosciences struck 'terrific arrangement' with Elanco, says Lake Street
12/01/20 Alliance Global Partners
Kindred price target lowered to $10.25 from $12.50 at Alliance Global
IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

02/17/21 Barclays
Idexx Laboratories initiated with an Overweight at Barclays
01/29/21 JPMorgan
Idexx Laboratories initiated with an Overweight at JPMorgan
08/17/20 Credit Suisse
Idexx Laboratories price target raised to $422 from $415 at Credit Suisse
08/04/20 Credit Suisse
Idexx Laboratories price target raised to $415 from $300 at Credit Suisse
PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

08/06/20 Morgan Stanley
Morgan Stanley cuts Phibro to Underweight on livestock pressure, antibiotic risk
08/06/20 Morgan Stanley
Phibro Animal Health downgraded to Underweight from Equal Weight at Morgan Stanley
ELAN Elanco
$32.14 /

+0.57 (+1.81%)

12/09/20 Argus
Elanco cut to Hold at Argus on margin pressure from Bayer unit deal
12/09/20 Argus
Elanco downgraded to Hold from Buy at Argus
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

KIN Kindred Biosciences
$4.74 /

+0.03 (+0.64%)

IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

HSKA Heska
$207.78 /

-0.35 (-0.17%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

  • 01
    Dec
ZTS Zoetis
$158.94 /

-0.1 (-0.06%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

PAHC Phibro Animal Health
$21.80 /

-0.04 (-0.18%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

IDXX Idexx Laboratories
$529.59 /

-3.96 (-0.74%)

ELAN Elanco
$32.14 /

+0.57 (+1.81%)

Recommendations
Heska price target raised to $230 from $167.50 at Alliance Global Partners » 08:29
02/24/21
02/24
08:29
02/24/21
08:29
HSKA

Heska

$197.00 /

+9.01 (+4.79%)

Alliance Global Partners…

Alliance Global Partners analyst Ben Haynor raised the firm's price target on Heska to $230 from $167.50 and reiterates a Buy rating on the shares following the company's Q4 beat. The underlying metrics of Heska's business are solid and management is being conservative in their guidance, Haynor tells investors in a research note.

ShowHide Related Items >><<
HSKA Heska
$197.00 /

+9.01 (+4.79%)

HSKA Heska
$197.00 /

+9.01 (+4.79%)

02/23/21 Piper Sandler
Heska price target raised to $220 from $157 at Piper Sandler
01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
11/04/20 Alliance Global Partners
Heska price target raised to $163.50 from $116.50 at Alliance Global Partners
HSKA Heska
$197.00 /

+9.01 (+4.79%)

Recommendations
Heska price target raised to $220 from $157 at Piper Sandler » 16:23
02/23/21
02/23
16:23
02/23/21
16:23
HSKA

Heska

$197.00 /

+9.01 (+4.79%)

Piper Sandler analyst…

Piper Sandler analyst Steven Mah raised the firm's price target on Heska to $220 from $157 and keeps an Overweight rating on the shares following the company's Q4 results. Heska's business model has shown "strong resiliency" despite COVID-19 headwinds, Mah tells investors in a research note. The analyst believes the company is positioned for long-term sustainable growth with upcoming product launches, entry into cytology increasing international traction, plus ongoing strength in pet ownership trends extending into 2021.

ShowHide Related Items >><<
HSKA Heska
$197.00 /

+9.01 (+4.79%)

HSKA Heska
$197.00 /

+9.01 (+4.79%)

01/29/21 JPMorgan
Heska initiated with an Overweight at JPMorgan
11/23/20 Piper Sandler
Heska price target raised to $157 from $150 at Piper Sandler
11/04/20 Alliance Global Partners
Heska price target raised to $163.50 from $116.50 at Alliance Global Partners
10/21/20 Raymond James
Heska upgraded to Outperform from Market Perform at Raymond James
HSKA Heska
$197.00 /

+9.01 (+4.79%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.